Mutations in human SUFU have been found in medulloblastoma [9] and prostate cancer [10], and SUFU loss of heterozygosity was observed in rhabdomyosarcoma (RMS) [11], implicating that SUFU is a tumor suppressor gene. This evidence concerns the gene SUFU and prostate carcinoma.